Creek Drive Management Group LLC
Position in NKTR — Nektar Therapeutics
CIK 2111824
SAN FRANCISCO, CA
Position in NKTR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$16,963,830
+$7,869,350 QoQ
Shares Held
243,000
+92.2% QoQ
Ownership
0.712%
of shares outstanding
% of Portfolio
10.62%
of 13F equity value
Holder Rank
#34
of 240 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NKTR Over Time
Shares Held
Position Value (USD)
Derivatives in NKTR
reported options exposure · as of Mar 31, 2026CallValue
$3,597,500
CallShares
50,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Creek Drive Management Group LLC holds $57,997,020 across 7 Biotechnology names. NKTR ranks #2 (29.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
157,500 | $20,988,450 | |
| 2 | NKTR |
Nektar Therapeutics
This page
|
243,000 | $16,963,830 | |
| 3 | QURE |
uniQure N.V.
|
337,000 | $15,522,220 | |
| 4 | RNA |
Atrium Therapeutics, Inc.
|
127,600 | $1,716,220 | |
| 5 | TENX |
Tenax Therapeutics, Inc.
|
74,000 | $1,076,700 | |
| 6 | PALI |
Palisade Bio, Inc.
|
440,000 | $919,600 | |
| 7 | PEPG |
PepGen Inc.
|
450,000 | $810,000 |
All Filings in NKTR
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,963,830 | 243,000 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,597,500 | 50,000 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $9,094,480 | 126,400 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,842,940 | 185,500 | Shares | Sole | 2026-02-18 | |
| No filing history on record for this holder in this stock. | ||||||